Rami B Ibrahim

Summary

Affiliation: Wayne State University
Country: USA

Publications

  1. ncbi request reprint Drug removal by plasmapheresis: an evidence-based review
    Rami B Ibrahim
    Department of Pharmacy, Karmanos Cancer Institute, 4100 John R, Detroit, MI 48201 2013, USA
    Pharmacotherapy 27:1529-49. 2007
  2. doi request reprint Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation
    Rami B Ibrahim
    Department of Pharmacy Karmanos Cancer Hospital, 4100 John R, Detroit, MI 48201 2013, USA
    J Oncol Pharm Pract 14:113-21. 2008
  3. doi request reprint Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime
    Rami B Ibrahim
    Department of Pharmacy, Karmanos Cancer Institute, 4100 John R, Detroit, MI 48201 2013, USA
    J Oncol Pharm Pract 15:217-22. 2009
  4. doi request reprint Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease
    Rami B Ibrahim
    Karmanos Cancer Institute and Wayne State University, Detroit, Michigan 48201, USA
    Biol Blood Marrow Transplant 15:395-405. 2009
  5. doi request reprint Immediate cross-hypersensitivity between micafungin and caspofungin: a case report
    Shruti Patel
    Wayne State University, Detroit, MI, USA
    J Oncol Pharm Pract 15:187-9. 2009
  6. ncbi request reprint Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient
    Ahmed Said
    Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, Michigan 48201, USA
    Pharmacotherapy 26:289-95. 2006
  7. ncbi request reprint Palifermin in a hematopoietic stem cell transplant patient with osteonecrosis of the jaw
    Leah A Yageman
    Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI 48201 2020, USA
    J Oncol Pharm Pract 12:119-21. 2006
  8. ncbi request reprint The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation
    Muneer H Abidi
    Division of Hematology and Oncology, Department of Pharmacy, Barbara Ann Karmanos Cancer Institute, Eugene Applebaum College of Pharmacy and Allied Health, Wayne State University, Detroit, Michigan 48201, USA
    Hematol Oncol 24:164-5. 2006
  9. doi request reprint Systemic absorption of topical lidocaine in a bone marrow transplant recipient with hepatic sinusoidal obstruction syndrome
    Bichoy H Gabra
    Karmanos Cancer Institute, Detroit, MI, USA
    Am J Health Syst Pharm 68:135-7. 2011
  10. ncbi request reprint Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant
    Muneer H Abidi
    Division of Hematology and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48109, USA
    Am J Hematol 82:932-3. 2007

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Drug removal by plasmapheresis: an evidence-based review
    Rami B Ibrahim
    Department of Pharmacy, Karmanos Cancer Institute, 4100 John R, Detroit, MI 48201 2013, USA
    Pharmacotherapy 27:1529-49. 2007
    ..Other considerations are the merits and pitfalls of the different methods used in published reports and recommendations for future pharmacokinetic studies in this field...
  2. doi request reprint Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation
    Rami B Ibrahim
    Department of Pharmacy Karmanos Cancer Hospital, 4100 John R, Detroit, MI 48201 2013, USA
    J Oncol Pharm Pract 14:113-21. 2008
    ..Collectively, these data suggest that AP effect on tacrolimus metabolism is of minor clinical significance. A controlled trial is needed to confirm these findings...
  3. doi request reprint Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime
    Rami B Ibrahim
    Department of Pharmacy, Karmanos Cancer Institute, 4100 John R, Detroit, MI 48201 2013, USA
    J Oncol Pharm Pract 15:217-22. 2009
    ..96, r(2) = 0.92; p<0.05). The above results suggest that, under the studied conditions, cefepime removal by PE is clinically insignificant (approximately 4% of total 2 g dose)...
  4. doi request reprint Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease
    Rami B Ibrahim
    Karmanos Cancer Institute and Wayne State University, Detroit, Michigan 48201, USA
    Biol Blood Marrow Transplant 15:395-405. 2009
    ..This review evaluates the current evidence of nonabsorbable corticosteroids in HSCT and sets forth recommendations for future trials with these agents...
  5. doi request reprint Immediate cross-hypersensitivity between micafungin and caspofungin: a case report
    Shruti Patel
    Wayne State University, Detroit, MI, USA
    J Oncol Pharm Pract 15:187-9. 2009
    ..It is recommended to avoid challenging patients with history of immediate hypersensitivity to one echinocandin with another...
  6. ncbi request reprint Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient
    Ahmed Said
    Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, Michigan 48201, USA
    Pharmacotherapy 26:289-95. 2006
    ..Preemptive sirolimus dosage reduction and close monitoring of its whole blood trough levels are required whenever this combination is considered to avoid immunosuppressant toxicity in already critically ill patients...
  7. ncbi request reprint Palifermin in a hematopoietic stem cell transplant patient with osteonecrosis of the jaw
    Leah A Yageman
    Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI 48201 2020, USA
    J Oncol Pharm Pract 12:119-21. 2006
    ..When contemplating palifermin as a mucosal protectant in a hematopoietic stem cell transplant patient with ONJ, a careful benefit-to-risk assessment is in order to ensure optimal effectiveness without undue harm...
  8. ncbi request reprint The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation
    Muneer H Abidi
    Division of Hematology and Oncology, Department of Pharmacy, Barbara Ann Karmanos Cancer Institute, Eugene Applebaum College of Pharmacy and Allied Health, Wayne State University, Detroit, Michigan 48201, USA
    Hematol Oncol 24:164-5. 2006
    ..We conclude that the clinical presentation of this patient after HSCT on dapsone therapy coincide with the sulfone syndrome not previously described in a patients after HSCT...
  9. doi request reprint Systemic absorption of topical lidocaine in a bone marrow transplant recipient with hepatic sinusoidal obstruction syndrome
    Bichoy H Gabra
    Karmanos Cancer Institute, Detroit, MI, USA
    Am J Health Syst Pharm 68:135-7. 2011
    ..A case of systemic lidocaine exposure in a bone marrow transplant recipient with severe hepatic sinusoidal obstruction syndrome (SOS) receiving treatment with lidocaine patch 5% is reported...
  10. ncbi request reprint Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant
    Muneer H Abidi
    Division of Hematology and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48109, USA
    Am J Hematol 82:932-3. 2007
    ..Her disease recurred and thalidomide therapy was started, with her overall disease burden significantly reduced as measured radiographically...
  11. ncbi request reprint Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity
    Rami B Ibrahim
    Karmanos Cancer Institute, Harper University Hospital, The Detroit Medical Center, 3990 John R, Detroit, MI 48201 2020, USA
    Ann Pharmacother 38:1053-9. 2004
    ..To describe the evidence assessing the use of anti-thrombin III (AT-III) in the management of toxicity associated with hematopoietic stem-cell transplantation (HSCT)-conditioning regimens...
  12. ncbi request reprint Cross-reactivity between paclitaxel and hazelnut: a case report
    Denise G Bukacel
    Department of Pharmacy, Karmanos Cancer Center, Farmington Hills, MI 48334, USA
    J Oncol Pharm Pract 13:53-5. 2007
    ..The hazelnut allergy may not be a nut-protein allergy at all, but rather an allergy to the components of paclitaxel that reside in the hazelnut itself...
  13. doi request reprint Dapsone-induced methemoglobinemia: a primer for clinicians
    James A Barclay
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 45:1103-15. 2011
    ..To present a comprehensive review of dapsone-induced methemoglobinemia and its management...